Uncategorized

Medicare Advantage payer Alignment has named longtime insurance executive Dawn Maroney president.

Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the second half of the year.

The notetaking assistant assistant will first be available to about 2,000 clinicians who serve around a million patients.

Amidst a “renaissance” of interest in neuropsychiatry, Seaport’s executive team is taking nothing for granted.

While investors and analysts push for a deal, Biogen CEO Chris Viehbacher and Head of Development Priya Singhal refuse to make one out of desperation.

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference. Meanwhile, Biogen proposes to acquire struggling neuro partner Sage, and obesity dominates discussions as Pfizer goes “all in.”

Experts say the future of AI regulation is uncertain in 2025 with a new presidential administration. Also this year, organizations will continue to bolster their cyber defenses to withstand increasing attacks.

Taken together with Keros’ recent pivot away from obesity, the termination of its pulmonary arterial hypertension study, could lead to a “difficult path ahead” for Keros, according to Guggenheim analysts.

A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare and commercial claims alike.

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year.